Disclosure Statement: Rare Cholestatic Liver Diseases CME Content
Are you equipped with the latest knowledge to identify rare cholestatic conditions before irreversible liver damage occurs?
Read the full articleYou might also wanna read
Management Concepts of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Among Chinese Physicians
Conditions : Liver Disease Interventions : Other: No treatment is given Sponsors : Novo Nordisk A/S Recruiting
"Exploring the Potential Benefits of Using Dapagliflozin in Cirrhotic Chronic Liver Disease Patients- A Randomized Controlled Trial"
Conditions : Ascites Hepatic Interventions : Drug: Dapagliflozin Sponsors : Beni-Suef University Recruiting
CME | Magic, Microdosing, and Moral Panic: A Primary Care Look at Substances with Abuse Potential
In this episode of CME on the Go, our hosts discuss the integration of psychedelic substances like ketamine, psilocybin, iboga, and various
British woman opens up about PSC diagnosis after years of fearing the rare liver condition
Michelle suffers with multiple health issues due to her condition
Diane walks to beat Primary Biliary Cholangitis (PBC)
Diane Reeves is a teacher in Solihull. She has Primary Biliary Cholangitis (PBC). It’s a rare, chronic and progressive autoimmune disease wh
mRNA technology: navigating preclinical research for rare diseases
Philip Cruz, Country Medical Director at Moderna UK talks about the potential of mRNA technology for rare diseases in a blog for Rare Diseas

Comments
Sign in to join the conversation.
No comments yet. Be the first.